Results 231 to 240 of about 5,456,142 (288)

Association Between Locomotive Syndrome and Metabolic Dysfunction‐Associated Steatotic Liver Disease in a Health Examination Cohort: A Cross‐Sectional Study

Hepatology Research, EarlyView.
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is associated with liver fat and other health problems. In this study of 7776 adults who underwent health examinations, early mobility impairment was more common in individuals with MASLD.
Shinya Yokoyama, Takanori Ito, Taku Tanaka, Hiroaki Hiraiwa, Takashi Honda, Yoji Ishizu, Norihiro Imai, Kenta Yamamoto, Kazuki Sahara, Tetsuhito Kojima, Naoyoshi Kariya, Hiroki Kawashima   +11 more
wiley   +1 more source

Lipocalin 13 Mitigates Metabolic Dysfunction-Associated Steatotic Liver Disease Through Inhibiting the ADRB2/ERK Signalling Pathway. [PDF]

Liver Int
Qin X, Hong Y, Ren W, Lei G, Zhou W, Wu S, Lin Z, Tan Y, Cao K, Wei Z, Shi H, Zhu X, Wei G.   +12 more
europepmc   +1 more source

Hepatic Steatosis Risk Is Positively Associated With Increased Intestinal Glucose Absorption

Diabetes, Obesity and Metabolism, EarlyView.
Braden D. Rose, Domenico Tricò, Christopher K. Rayner, Tongzhi Wu, Richard L. Young   +4 more
wiley   +1 more source

Clinical Outcomes of Gradual Corticosteroid Tapering for Immune Checkpoint Inhibitor‐Induced Liver Injury

Hepatology Research, EarlyView.
Patients with severe ICI‐induced liver injury are commonly treated with corticosteroids, but the optimal tapering strategy remains uncertain. In this study, a gradual corticosteroid tapering strategy based partly on Japanese clinical practice for autoimmune hepatitis was associated with a low rate of relapse and enabled many patients to safely resume ...
Naoto Soma, Yoshihito Uchida, Kayoko Sugawara, Masamitsu Nakao, Nobuaki Nakayama, Yukinori Imai, Suguru Mizuno, Satoshi Mochida   +7 more
wiley   +1 more source

Sex Difference in the Impact of Steatotic Liver Disease on Incident Hepatocellular Carcinoma in Patients with Chronic Hepatitis B. [PDF]

Cancers (Basel)
Wu WJ, Tien CH, Lin CL, Liu CJ, Hu JT, Liou JM, Yu MW.   +6 more
europepmc   +1 more source

Validation of the Baveno Endoscopy Avoidance Criteria in Japanese Patients With Chronic Liver Disease: A Real‐World Cohort Study

Hepatology Research, EarlyView.
Many patients with chronic liver disease can safely avoid unnecessary screening endoscopy using the Baveno VII criteria. We developed a simple three‐factor score to identify patients at high risk of serious esophageal varices. Using both approaches together may improve the efficiency and safety of endoscopic screening.
Maiko Asami, Yoshihito Uchida, Shohei Tsuji, Satsuki Ando, Kayoko Sugawara, Masamitsu Nakao, Nobuaki Nakayama, Yukinori Imai, Suguru Mizuno, Satoshi Mochida   +9 more
wiley   +1 more source

The Latest Therapeutic Targets and New Drug Research of Metabolic Dysfunction-Associated Steatotic Liver Disease. [PDF]

Clin Pharmacol Ther
Xiu H, Li T, Wen J, Li Z, Wu J, Fu X, Zhang C, Yang Z, Yao X, Xu Z.   +9 more
europepmc   +1 more source

Defining Weight‐Loss‐Independent Hepatic Effects of Incretin‐Based Therapies

Diabetes, Obesity and Metabolism, EarlyView.
Mingyuan Zhang, Hanyang Liu, Yawen Hao, Lanlan Chen   +3 more
wiley   +1 more source

Maternal Dyslipidaemia Aggravates Offspring Metabolic Dysfunction-Associated Steatotic Liver Disease. [PDF]

Basic Clin Pharmacol Toxicol
Pedersen K, Buhl SF, Højgaard-Jensen C, Lykkesfeldt J, Tveden-Nyborg P.   +4 more
europepmc   +1 more source